Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions

GLIA

Volumn 62, Issue 10, 2014, Pages 1645-1658

  Lieury, Alice ^a,b   Chanal, Marie ^a,b   Androdias, Géraldine ^a,b,c   Reynolds, Richard ^d   Cavagna, Sylvie ^a   Giraudon, Pascale ^a   Confavreux, Christian ^a,b,c   Nataf, Serge ^a,b,e  

^a LYON NEUROSCIENCE RESEARCH CENTER   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Astrocyte; Axonal loss; Demyelination; Microglia; Multiple sclerosis; Periplaque

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ANGIOTENSINOGEN; AQUAPORIN 4; AXONIN 1; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CLAUDIN 11; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; CONNEXIN 43; CONNEXIN 47; EXCITATORY AMINO ACID TRANSPORTER 1; HERMES ANTIGEN; INTERLEUKIN 27; JUNCTIONAL ADHESION MOLECULE C; KALLIKREIN 6; MESSENGER RNA; MYELIN; MYELIN BASIC PROTEIN; MYOSIN VA; NIBRIN; PROTEASE NEXIN I; PROTEIN S100B; PROTEOLIPID PROTEIN; SIRTUIN 2; STEM CELL FACTOR; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR SOX8; TRANSFERRIN RECEPTOR; AQP4 PROTEIN, HUMAN; GJA1 PROTEIN, HUMAN; SLC1A3 PROTEIN, HUMAN;

ARTICLE; ASTROCYTE; AUTOPSY; BRAIN TISSUE; CERVICAL SPINAL CORD; CONTROLLED STUDY; DEMYELINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LASER CAPTURE MICRODISSECTION; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBER; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINAL CORD LESION; TISSUE REPAIR; WESTERN BLOTTING; ADULT; CERVICAL SPINE; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SPINAL CORD;

ADULT; AQUAPORIN 4; CERVICAL VERTEBRAE; CONNEXIN 43; EXCITATORY AMINO ACID TRANSPORTER 1; FEMALE; HUMANS; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MYELIN SHEATH; OLIGODENDROGLIA; PHAGOCYTOSIS; SPINAL CORD;

EID: 84906312765     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22705     Document Type: Article

References (62)

1. Altevogt BM, Paul DL. 2004. Four classes of intercellular channels between glial cells in the CNS. J Neurosci 24:4313-4323.
2. Androdias G, Reynolds R, Chanal M, Ritleng C, Confavreux C, Nataf S. 2010. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol 68:465-476.
3. Asai H, Kakita H, Aoyama M, Nagaya Y, Saitoh S, Asai K. 2013. Diclofenac enhances proinflammatory cytokine-induced aquaporin-4 expression in cultured astrocyte. Cell Mol Neurobiol 33:393-400.
4. Back SA, Tuohy TMF, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF, Rao MS, Sherman LS. 2005. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966-972.
5. Baker BJ, Park KW, Qin H, Ma X, Benveniste EN. 2010. IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 58:1082-1093.
6. Bennett MVL, Garré JM, Orellana JA, Bukauskas FF, Nedergaard M, Sáez JC. 2012. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Res 1487:3-15.
7. Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD. 2000. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893-901.
8. Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H. 2010. Demyelination versus remyelination in progressive multiple sclerosis. Brain 133:2983-2998.
9. Brosnan CF, Raine CS. 2013. The astrocyte in multiple sclerosis revisited. Glia 61:453-465.
10. Brück W, Kuhlmann T, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206:181-185.
11. Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD. 2012. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann Neurol 72:918-926.
12. Charcot J-M. 1865. Sclérose des cordons latéraux de la moelle épinière, chez une femme hystérique, atteinte de contracture permanente des quatre membres. Bull Mem Soc Med Hop Paris II:24-35.
13. Colombo E, Cordiglieri C, Melli G, Newcombe J, Krumbholz M, Parada LF, Medico E, Hohlfeld R, Meinl E, Farina C. 2012. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J Exp Med 209:521-535.
14. Confavreux C, Compston A. 2006. The natural history of multiple sclerosis. In: Compston A, editor. McAlpine's multiple sclerosis, 4th ed. London: Churchill.
15. Confavreux C, Vukusic S, Adeleine P. 2003. Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process. Brain 126:770-782.
16. Confavreux C, Vukusic S, Moreau T, Adeleine P. 2000. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430-1438.
17. Cunningham C. 2013. Microglia and neurodegeneration: The role of systemic inflammation. Glia 61:71-90.
18. Farina C, Aloisi F, Meinl E. 2007. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28:138-145.
19. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
20. Filippi M, Rocca M. 2010. Dirty-appearing white matter: A disregarded entity in multiple sclerosis. AJNR Am J Neuroradiol 31:389-390.
21. Fischer MT, Wimmer I, Höftberger R, Gerlach S, Haider L, Zrzavy T, Hametner S, Mahad D, Binder CJ, Krumbholz M, Bauer J, Bradl M, Lassmann H. 2013. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136:1799-1815.
22. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H. 2009. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175-1189.
23. Froger N, Orellana JA, Calvo C-F, Amigou E, Kozoriz MG, Naus CC, Sáez JC, Giaume C. 2010. Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective. Mol Cell Neurosci 45:37-46.
24. Ge Y, Grossman RI, Babb JS, He J, Mannon LJ. 2003. Dirty-appearing white matter in multiple sclerosis: Volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 24:1935-1940.
25. Giaume C, Leybaert LC, Naus CC, Sáez J. 2013. Connexin and pannexin hemichannels in brain glial cells: Properties, pharmacology, and roles. Front Pharmacol 4:88.
26. Henderson APD, Barnett MH, Parratt JDE, Prineas JW. 2009. Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Ann Neurol 66:739-753.
27. Hirase T, Hara H, Miyazaki Y, Ide N, Nishimoto-Hazuku A, Fujimoto H, Saris CJM, Yoshida H, Node K. 2013. Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice. Am J Physiol Heart Circ Physiol 305:H420-H429.
28. Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R. 2010. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 69:1017-1033.
29. Ito H, Yamamoto N, Arima H, Hirate H, Morishima T, Umenishi F, Tada T, Asai K, Katsuya H, Sobue K. 2006. Interleukin-1beta induces the expression of aquaporin-4 through a nuclear factor-kappaB pathway in rat astrocytes. J Neurochem 99:107-118.
30. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. 2005. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705-712.
31. Lassmann H. 2014. Mechanisms of white matter damage in multiple sclerosis. Glia 1-15.
32. Lassmann H, Brück W, Lucchinetti CF. 2007. The immunopathology of multiple sclerosis: An overview. Brain Pathol 17:210-218.
33. Li M, Ransohoff RM. 2008. Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology. Prog Neurobiol 84:116-131.
34. Lovas G, Szilágyi N, Majtényi K, Palkovits M, Komoly S. 2000. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123:308-317.
35. Man S, Tucky B, Cotleur A, Drazba J, Takeshita Y, Ransohoff RM. 2012. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier. Sci Transl Med 4:1-18.
36. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686.
37. Markoullis K, Sargiannidou I, Schiza N, Hadjisavvas A, Roncaroli F, Reynolds R, Kleopa K. 2012. Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 123:873-886.
38. Melief J, Schuurman KG, van de Garde MDB, Smolders J, van Eijk M, Hamann J, Huitinga I. 2013. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed. Glia 61:1848-1861.
39. Miller DH, Thompson a J, Filippi M. 2003. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 250:1407-1419.
40. Misu T, Fujihara K, Kakita a, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y. 2007. Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis. Brain 130:1224-1234.
41. Moore GRW, Laule C, Mackay A, Leung E, Li DKB, Zhao G, Traboulsee AL, Paty DW. 2008. Dirty-appearing white matter in multiple sclerosis: Preliminary observations of myelin phospholipid and axonal loss. J Neurol 255:1802-1811, discussion 1812.
42. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T. 2008. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18:52-61.
43. Nijeholt GJ, Bergers E, Kamphorst W, Bot J, Nicolay K, Castelijns J a, van Waesberghe JH, Ravid R, Polman CH, Barkhof F. 2001. Postmortem high-resolution MRI of the spinal cord in multiple sclerosis: A correlative study with conventional MRI, histopathology and clinical phenotype. Brain 124:154-166.
44. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129:3165-3172.
45. Patrucco L, Rojas JI, Cristiano E. 2012. Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes. J Neurol 259:1317-1320.
46. Prineas JW, Connell F. 1979. Remyelination in multiple sclerosis. Ann Neurol 5:22-31.
47. Prineas JW, Kwon EE, Cho E-S, Sharer LR, Barnett MH, Oleszak EL, Hoffman B, Morgan BP. 2001. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50:646-657.
48. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. 2007. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194-1205.
49. Ropele S, Strasser-Fuchs S, Augustin M, Stollberger R, Enzinger C, Hartung HP, Fazekas F. 2000. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 21:1885-1891.
50. Seewann A, Vrenken H, Valk P Van Der Blezer ELA, Knol DL, Castelijns JA, Polman CH, Pouwels PJW, Barkhof F, Geurts JJG. 2009. Diffusely abnormal white matter in chronic multiple sclerosis. Arch Neurol 66:601-609.
51. Sinclair C, Kirk J, Herron B, Fitzgerald U, McQuaid S. 2007. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 113:187-194.
52. Tanabe S, Heesen M, Yoshizawa I, Berman MA, Luo Y, Bleul CC, Springer TA, Okuda K, Gerard N, Dorf ME. 1997. Functional expression. J Immunol 159:905-911.
53. Tilleux S, Goursaud S, Hermans E. 2009. Selective upregulation of GLT-1 in cultured astrocytes exposed to soluble mediators released by activated microglia. Neurochem Int 55:35-40.
54. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
55. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
56. Vallejo-Illarramendi A, Domercq M, Pérez-Cerdá F, Ravid R, Matute C. 2006. Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21:154-164.
57. Vincent FB, SauleP Easton D, Figgett WA, Fairfax KA, Mackay F. 2013. The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 24:203-215.
58. Vogel DYS, Vereyken EJF, Glim JE, Heijnen PD a M, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD. 2013. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation 10:35.
59. Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJG. 2010. Diffusely abnormal white matter in progressive multiple sclerosis: In vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am J Neuroradiol 31:541-548.
60. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. 2008. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288-303.
61. Zhang F, Yao S-Y, Whetsell WO, Sriram S. 2013a. Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination. Glia 61:1261-1273.
62. Zhang Y, Moore GRW, Laule C, Bjarnason T a, Kozlowski P, Traboulsee A, Li DKB. 2013b. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis. Ann Neurol 74:91-99.